FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943399237> ?p ?o ?g. }

• W2943399237 abstract "The RELIGHT clinical trial used an individualised treatment regimen of ranibizumab to treat diabetic macular oedema (DMO). We report findings from two patient-reported outcome instruments.The National Eye Institute Visual Function Questionnaire (NEI-VFQ) was administered before starting treatment (M0) and at M6, 12 and 18. The Macular Disease Society Treatment Satisfaction Questionnaire (MacTSQ) was administered 1 month after treatment start (M1) and at M6, 12 and 18. Relationships between best-corrected visual acuity (BCVA) in the study eye (SE) and the status of the eye at baseline (as better or worse eye by BCVA) and the two instrument measures were investigated.BCVA in the SE correlated strongly with the NEI-VFQ composite scores and the majority of the subscales but not with the MacTSQ subscales. Statistically significant improvements were observed in the majority of the subscales of the NEI-VFQ at M6, 12 and 18. For the MacTSQ, improvements between baseline M6, 12 and 18 were seen for subscale 1 but only reached statistical significance at M12. In subscale 2, the changes in mean scores were statistically significant at all timepoints.Although ranibizumab treatment in DMO over an 18-month period resulted in improvements in visual functioning and patient satisfaction, no correlation was found between the instruments used to measure these outcomes. Our finding of a lack of correlation between BCVA and the MacTSQ suggests the presence of psychophysical factors not measured by traditional means." @default.
• W2943399237 created "2019-05-09" @default.
• W2943399237 creator A5019521414 @default.
• W2943399237 creator A5023871553 @default.
• W2943399237 creator A5035946370 @default.
• W2943399237 creator A5052972977 @default.
• W2943399237 creator A5066434934 @default.
• W2943399237 creator A5068072154 @default.
• W2943399237 creator A5070932279 @default.
• W2943399237 creator A5071015343 @default.
• W2943399237 creator A5076804842 @default.
• W2943399237 creator A5079827750 @default.
• W2943399237 creator A5086158707 @default.
• W2943399237 date "2019-04-01" @default.
• W2943399237 modified "2023-10-01" @default.
• W2943399237 title "Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema" @default.
• W2943399237 cites W1547832571 @default.
• W2943399237 cites W166689194 @default.
• W2943399237 cites W1963693586 @default.
• W2943399237 cites W1977221974 @default.
• W2943399237 cites W1978535807 @default.
• W2943399237 cites W1998902846 @default.
• W2943399237 cites W2000333599 @default.
• W2943399237 cites W2001483085 @default.
• W2943399237 cites W2041509891 @default.
• W2943399237 cites W2051937264 @default.
• W2943399237 cites W2068575303 @default.
• W2943399237 cites W2096060458 @default.
• W2943399237 cites W2096257972 @default.
• W2943399237 cites W2108535474 @default.
• W2943399237 cites W2161279821 @default.
• W2943399237 cites W2169446282 @default.
• W2943399237 cites W2610772121 @default.
• W2943399237 cites W2782908833 @default.
• W2943399237 cites W2787406758 @default.
• W2943399237 cites W4250968058 @default.
• W2943399237 cites W78778186 @default.
• W2943399237 doi "https://doi.org/10.1136/bmjophth-2018-000226" @default.
• W2943399237 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6528749" @default.
• W2943399237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31179389" @default.
• W2943399237 hasPublicationYear "2019" @default.
• W2943399237 type Work @default.
• W2943399237 sameAs 2943399237 @default.
• W2943399237 citedByCount "2" @default.
• W2943399237 countsByYear W29433992372020 @default.
• W2943399237 countsByYear W29433992372021 @default.
• W2943399237 crossrefType "journal-article" @default.
• W2943399237 hasAuthorship W2943399237A5019521414 @default.
• W2943399237 hasAuthorship W2943399237A5023871553 @default.
• W2943399237 hasAuthorship W2943399237A5035946370 @default.
• W2943399237 hasAuthorship W2943399237A5052972977 @default.
• W2943399237 hasAuthorship W2943399237A5066434934 @default.
• W2943399237 hasAuthorship W2943399237A5068072154 @default.
• W2943399237 hasAuthorship W2943399237A5070932279 @default.
• W2943399237 hasAuthorship W2943399237A5071015343 @default.
• W2943399237 hasAuthorship W2943399237A5076804842 @default.
• W2943399237 hasAuthorship W2943399237A5079827750 @default.
• W2943399237 hasAuthorship W2943399237A5086158707 @default.
• W2943399237 hasBestOaLocation W29433992371 @default.
• W2943399237 hasConcept C118487528 @default.
• W2943399237 hasConcept C119767625 @default.
• W2943399237 hasConcept C126322002 @default.
• W2943399237 hasConcept C134018914 @default.
• W2943399237 hasConcept C141071460 @default.
• W2943399237 hasConcept C2775944032 @default.
• W2943399237 hasConcept C2776694085 @default.
• W2943399237 hasConcept C2777802072 @default.
• W2943399237 hasConcept C2778257484 @default.
• W2943399237 hasConcept C2779829184 @default.
• W2943399237 hasConcept C2780699112 @default.
• W2943399237 hasConcept C2781100027 @default.
• W2943399237 hasConcept C2781413609 @default.
• W2943399237 hasConcept C535046627 @default.
• W2943399237 hasConcept C555293320 @default.
• W2943399237 hasConcept C65409693 @default.
• W2943399237 hasConcept C71924100 @default.
• W2943399237 hasConceptScore W2943399237C118487528 @default.
• W2943399237 hasConceptScore W2943399237C119767625 @default.
• W2943399237 hasConceptScore W2943399237C126322002 @default.
• W2943399237 hasConceptScore W2943399237C134018914 @default.
• W2943399237 hasConceptScore W2943399237C141071460 @default.
• W2943399237 hasConceptScore W2943399237C2775944032 @default.
• W2943399237 hasConceptScore W2943399237C2776694085 @default.
• W2943399237 hasConceptScore W2943399237C2777802072 @default.
• W2943399237 hasConceptScore W2943399237C2778257484 @default.
• W2943399237 hasConceptScore W2943399237C2779829184 @default.
• W2943399237 hasConceptScore W2943399237C2780699112 @default.
• W2943399237 hasConceptScore W2943399237C2781100027 @default.
• W2943399237 hasConceptScore W2943399237C2781413609 @default.
• W2943399237 hasConceptScore W2943399237C535046627 @default.
• W2943399237 hasConceptScore W2943399237C555293320 @default.
• W2943399237 hasConceptScore W2943399237C65409693 @default.
• W2943399237 hasConceptScore W2943399237C71924100 @default.
• W2943399237 hasFunder F4320332756 @default.
• W2943399237 hasLocation W29433992371 @default.
• W2943399237 hasLocation W29433992372 @default.
• W2943399237 hasLocation W29433992373 @default.
• W2943399237 hasLocation W29433992374 @default.
• W2943399237 hasOpenAccess W2943399237 @default.
• W2943399237 hasPrimaryLocation W29433992371 @default.

• next